|
|
 |
|
Viewing report
|
|
|
|
Distributor Analysis in Nigeria
Frost & Sullivan, Dec 2010, Pages: 85
Distributor Analysis in Nigeria provides a detailed analysis of the distribution landscape in the Nigerian healthcare industry. The research service analyses Nigeria's healthcare environment, focusing on pharmaceuticals and medical device segments. The pharmaceutical market is further segmented into generic and branded drug segments. For each of these segments, market revenue forecasts are provided from 2009 up to 2016. The core of the research is a thorough analysis of the distribution landscape, specifically examining the distribution structure and channel, distribution challenges, regulatory requirements, key distribution trends and company profiles of key distributors.
This research service titled Distributor Analysis in Nigeria provides an analysis of the pharmaceutical distribution landscape in Nigeria, and company profiles of major distributors. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: pharmaceuticals and medical devices.
Market Overview:
Improved Regulatory Environment to Promote Expansion of the Nigerian Pharmaceutical Market
The informal sector in Nigeria is one of the chief sources of drugs for retail businesses for resell to end-users. Despite the surge in informal trade in recent years, the formal sector however remains the most important channel of supply. In the past, the lack of appropriate regulations and enforcement has fuelled concerns about the quality and legitimacy of products, thus affecting all drug suppliers including formal distributors and suppliers. This is however poised to change in future with the improving regulatory environment.
“Growth in the pharmaceutical market is expected to be driven by the increasing availability of low-cost generic drugs and an improving regulatory system,” notes the analyst of this research. An improved regulatory system is anticipated to boost uptake of drugs by inspiring end-user confidence and eliminating competition from illegal imports and sub-standard products.
Leakage of Supply into Informal Sector presents Key Challenge:
The leakage of supply into the informal sector has been a key challenge for manufacturers as quality assurance mechanisms cannot be enforced. These include monitoring of storage conditions and product expiration - all factors that affect treatment outcomes. As the informal sector is very important source of drugs for retail businesses, it has affected customer confidence in some pharmacies and distributors. “Although it is difficult to regulate the informal sector adequately, the regulatory agency, NAFDAC, has been making considerable progress in reducing the problem of sub-standard and illegal products,” remarks the analyst. “Recent interventions which include the introduction of the Drug Distribution Inspection Committee (DDIC) will improve enforcement through regular inspection of documentation throughout the supply chain.”
Through vertical integration, manufacturers in Nigeria are now moving into distribution, and gaining greater control of the supply chain. The major manufacturers in the country are setting up their own distribution subsidiaries that distribute directly to retail pharmacies and patent medicine vendors (PMVs).
“Since PMVs are more likely to purchase supplies through the informal sector, supplier relationship with these outlets has to improve through education and training,” advises the analyst.
Market Sectors:
Expert Frost & Sullivan analysts thoroughly examine the following segments in this research:
- Pharmaceuticals
- Medical devices
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
